Global General Anesthesia Drugs market: Propofol to account for more than 34% share by 2025; Global Industry Analysis and Opportunity Assessment, 2015 – 2025
- Published: Sep, 2015
- Report Code: REP-GB-388
-
Format:
An Incisive, In-depth Analysis on the General Anesthesia Drugs Market
This study offers a comprehensive, 360 degree analysis on the General Anesthesia Drugs market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global General Anesthesia Drugs market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Introduction
General anesthesia drugs are used to induce a sedative state in patients who are to go through a surgical procedure. Further, general anesthesia drugs can be segmented into two sub-segments based on the route of administration, general anesthesia drugs administered through the intravenous route is categorized as an intravenous anaesthetic and general anesthesia drugs administered through inhalation is categorized as an inhalation anaesthetic. It is a must to maintain the sedative stage in the patient during a surgical procedure, usually for this stage, inhalation anaesthesia are administered to the patients; while for the induction stage, intravenous general anaesthesia s is preferred.
Market Value and Forecast
In terms of value, the global general anesthesia drugs market is estimated to expand at a CAGR of 3.8% during the forecast period. Moreover, global general anesthesia drugs markets value is expected to increase to US$ 5,549.7 Mn by 2025 end.
Market Dynamics
Growth of the global general anesthesia drugs market is mainly driven by rising incidences of cardiovascular diseases, chronic respiratory diseases, craniomaxillofacial surgeries and accidents. However, lack of a single effective drug for all type of surgeries, side effects and complications during the surgical procedure, lack of skilled anaesthesiologists and certified registered nurse anaesthesiologists, inadequate insurance coverage, coupled with high prices of these drugs are restraining market growth.
In addition, side effects such as nausea, vomiting, allergy, sleep apnea and complications during surgical procedures are anticipated to drive the demand for improvement in the quality of drugs.
Segmentation by Product
The global general anesthesia drugs market is segmented on the basis of molecule/product. In terms of value, the propofol segment is estimated to account for over 29.8% share to the global general anesthesia drugs market by 2015 end and is expected to remain dominant during the forecast period.
.png)
Key Regions
The global general anesthesia drugs market has been segmented into seven major regions, namely: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa. In terms of value, North America is estimated to dominate the market with 31.0% share of the overall general anesthesia drugs market by 2015 end. APEJ is estimated to be the fastest-growing market, registering a CAGR of 5.2% in terms of value, over the forecast period.
Key Players
Some of the key players identified in the global general anesthesia drugs market report include Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc. These players are focused on developing new drugs with minimum side effects and maximum efficacy to seize the maximum of the global market share.
Future Market Insights offers a 10-year forecast of the global general anesthesia drugs market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 3.8% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the general anesthesia drugs market over the forecast period.
Report Description
This Future Market Insights report examines the general anesthesia drugs market for the period of 2015–2025. The primary objective of the report is to offer insights into developments in the general anesthesia drugs market that are significantly transforming global businesses and enterprises. Increasing incidences of cardiovascular and chronic diseases, coupled with rising demand for surgical procedures is predicted to increase usages of general anesthesia drugs worldwide. This is expected to bolster growth of the general anesthesia drugs market over the next five to six years. Increasing demand for inhalation general anesthesia drugs, for maintaining the sedative stage during surgical procedures, especially among the children and elderly population is expected to drive growth of general anesthesia drugs market during the forecast period. Companies are focused on populations driving the market such as: Asia Pacific and MEA, where incidences of cardiovascular and chronic disease are increasing, this is expected to further increase the demand of general anesthesia drugs during surgical procedures.
The general anesthesia drugs market report begins with an overview of the general anesthesia drugs market in terms of value. This section includes FMI’s analysis of key trends, drivers and restraints, and opportunity, all factors that are influencing the general anesthesia drugs market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the general anesthesia drugs market report to better equip clients with crystal clear decision-making insights.
The global general anesthesia drugs market is segmented on the basis of products type as: Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam and Others.A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and BPS analysis, for general anesthesia drugs market across the globe.
The next section of the report highlights general anesthesia drugs adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the general anesthesia drugs market. The study discusses the key regional trends contributing to growth of the general anesthesia drugs market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.
All the above sections, by product type and region, evaluate the present scenario and growth prospects of the general anesthesia drugs market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the following 12 months.
To calculate general anesthesia drugs market size, we have also considered revenue generated by the manufacturers. The forecast presented here assesses the total revenue by value across the general anesthesia drugs market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the general anesthesia drugs market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.
In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the general anesthesia drugs market.
As previously highlighted, the general anesthesia drugs market is split into a number of segments. All the general anesthesia drugs segments in terms of product and regions are analysed in terms of Basis Point Share to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the general anesthesia drugs market.
Another key feature of this report is the analysis of all key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the general anesthesia drugs market.
To understand key growth segments in terms of growth and adoption for —cardiovascular disease (CVD) and chronic disease— surgical procedures across the globe in the near future, Future Market Insights developed the general anesthesia drugs market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.
In the final section of the report, general anesthesia drugs a ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the general anesthesia drugs product portfolio and key differentiators. Key categories of providers covered in the report are general anaesthesia drug manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the general anesthesia drugs value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in general anesthesia drugs marketplace.
Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the general anesthesia drugs market. Key competitors covered in terms of manufacturers are: Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA and Hospira Inc.
Key Segments Covered
-
Product Type
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
Key Regions/Countries Covered
-
North America
- US
- Canada
-
Latin America
- Brazil
- Argentina
- Mexico
-
Western Europe
- EU5
- Nordics
- BENELUX
- Rest of Western Europe
-
Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
-
Asia Pacific Excluding Japan (APEJ)
- Greater China
- India
- ASEAN
- Australia and New Zealand
- Rest of APEJ
- Japan
-
Middle East & Africa
- GCC
- South Africa
- Israel
- Turkey
- Rest of MEA
Key Companies
- Baxter International Inc.
- AstraZeneca
- AbbVie Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Hospira Inc.
General Anesthesia Drugs Market Reports - Table of Contents
General Anesthesia Drugs Market Reports - List of Tables
Table 1: Global General Anaesthesia Drugs Market Value Forecast by Product, 2015 & 2025 (US$ Mn)
Table 2: Global General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 3: North America General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$Mn)
Table 4: U.S. General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 5: Canada General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 6: Latin America General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 7: Argentina General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 8: Brazil General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 9: Mexico General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 10: Rest of Latin America General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 11: Western Europe General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 12: Germany General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 13: U.K. General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 14: France General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 15: Italy General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 16: Spain General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 17: NORDIC General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 18: BENELUX General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 19: Rest of Western Europe General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 20: Eastern Europe General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 21: Poland General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 22: Russia General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 23: Rest of Eastern Europe General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 24: APEJ General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 25: Greater China General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 26: India General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 27: ASEAN General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 28: Australia and New Zealand General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 29: Rest of APEJ General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 30: Japan General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 31: MEA General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 32: GCC General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 33: South Africa General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 34: Israel General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 35: Turkey General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
Table 36: Rest of MEA General Anaesthesia Drugs Market Value Forecast By Product, 2013–2025 (US$ Mn)
General Anesthesia Drugs Market Reports - List of Figures
Figure 1: Global General Anaesthesia Drugs Market Value Forecast, 2013–2025
Figure 2: Global General Anaesthesia Drugs Market
Figure 3: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity, 2013–2025
Figure 4: Global General Anaesthesia Drugs Market Value and Y-o-Y Growth
Figure 5: Global General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 6: Global General Anaesthesia Drugs Market Y-o-Y Growth Comparison By Product, 2015 & 2020
Figure 7: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Propofol, 2014–2025
Figure 8: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Propofol, 2014–2020
Figure 9: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Sevoflurane, 2014–2025
Figure 10: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Sevoflurane, 2014–2020
Figure 11: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Dexmedetomidine, 2014–2025
Figure 12: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Dexmedetomidine, 2014–2020
Figure 13: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Desflurane, 2014–2025
Figure 14: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Desflurane, 2014–2020
Figure 15: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Remifentanil, 2014–2025
Figure 16: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Remifentanil, 2014–2020
Figure 17: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Midazolam, 2014–2025
Figure 18: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Midazolam, 2014–2020
Figure 19: Global General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast By Others, 2014–2025
Figure 20: Global General Anaesthesia Drugs Market Value Absolute $ Opportunity By Others, 2014–2020
Figure 21: Global General Anaesthesia Drugs Market Value Share & BPS Analysis By Region, 2015, 2020 & 2025
Figure 22: North America General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 23: North America General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2025
Figure 24: North America General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 25: North America General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product, 2015–2025
Figure 26: Latin America General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 27: Latin America General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2020
Figure 28: Latin America General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 29: Latin America General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Figure 30: Western Europe General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 31: Western Europe General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2025
Figure 32: Western Europe General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 33: Western Europe General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Figure 34: Eastern Europe General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 35: Eastern Europe General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2020
Figure 36: Eastern Europe General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 37: Eastern Europe General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Figure 38: APEJ General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 39: APEJ General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2020
Figure 40: APEJ General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 41: APEJ General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Figure 42: Japan General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 43: Japan General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2020
Figure 44: Japan General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 45: Japan General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Figure 46: MEA General Anaesthesia Drugs Market Value & Y-o-Y Growth Forecast, 2013–2025
Figure 47: MEA General Anaesthesia Drugs Market Absolute $ Opportunity, 2013–2020
Figure 48: MEA General Anaesthesia Drugs Market Value Share & BPS Analysis By Product, 2015, 2020 & 2025
Figure 49: MEA General Anaesthesia Drugs Market Y-o-Y Growth Forecast, By Product 2015-2025
Get in touch
Harish Tiwari
Global Head - Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.